2 - Level 2 (CORE)

Schedule: On Demand (The original live program aired on September 20, 2011 at 7:00pm EST) Program Overview The faculty reviewed results from clinical trials evaluating dietary approaches to weight loss and weight loss maintenance. Effects on body weight, body composition and cardiovascular... more

3
Average: 3 (2 votes)

In his presentation, Dr Westman sought to dispel some "myths" and answer criticisms about the low-carbohydrate (low-carb) diet. He maintains that someone in a wheelchair can lose weight, even if they do not exercise, just by changing their diet. more

5
Average: 5 (1 vote)

Schedule: On Demand (The original live program aired on Thursday, September 6, 2012) Program Overview: In large landmark trials, reduction in low-density lipoprotein cholesterol (LDL-C) levels with statins has been shown to decrease the incidence of major cardiovascular events by 25-45%.... more

4
Average: 4 (1 vote)

Schedule: On Demand (The original live program aired on May 16, 2012 8:00 PM EST) Program Overview: Statin treatment may be associated with adverse effects on glucose metabolism. Concerns have been raised regarding the effects of statin therapy on diabetes incidence and glycemic control. Join... more

4
Average: 4 (1 vote)

Schedule: On Demand (The original live program aired on Tuesday, December 18, 2012) Program Overview: This program will analyze results of a recent single-arm, open-label, phase 3 study. Dr. Daniel Rader will discuss microsomal triglyceride transfer protein inhibitor in patients with... more

4
Average: 4 (1 vote)

Schedule: On Demand (The original live program aired on Wednesday, October 8, 2014) This edition of Lipid Insights was hosted by the Northeast Lipid Association. Program Overview The Lipid Insights Virtual Journal Club, a 60-minute CME Webcast with a live Q&A session, is designed... more

4
Average: 4 (1 vote)

According to Dr. Chapman, there are a number of therapeutic agents on the horizon that normalize levels of Apolipoprotein A-I (ApoA-I) and high-density lipoprotein cholesterol (HDL-C) for the acute and/or chronic treatment of patients at high cardiometabolic risk.

4
Average: 4 (1 vote)

Schedule: On Demand (The original live program aired on December 15, 2011 at 7:00pm EST) Program Overview: The preliminary release of data from the AIM-HIGH trial left clinicians asking questions about the role of niacin therapy and raising HDL-C in patients at LDL goal. The final results from... more

3
Average: 3 (1 vote)

Schedule: On Demand (The original live program aired on Tuesday, November 27, 2012) Program Overview: What is the role of omega-3 fatty acids in preventing cardiovascular disease? A decade ago the AHA endorsed their use in secondary prevention, but several recent trials have shown no benefit... more

3
Average: 3 (1 vote)

Schedule: On Demand (The original live program aired on Tuesday, March 12, 2013) Program Overview: HoFH is a rare genetic condition that causes severe hypercholesterolemia and leaves patients at extremely high risk for premature coronary heart disease (CHD). Controlling dyslipidemia through... more

4.333335
Average: 4.3 (3 votes)